Zobrazeno 1 - 10
of 260
pro vyhledávání: '"E Jason, Abel"'
Autor:
Ali Ghasemzadeh, Eric T. Wendt, Brendan Dolan, Juliana Craig, Glenn O. Allen, E. Jason Abel, Daniel D. Shapiro
Publikováno v:
Frontiers in Urology, Vol 3 (2023)
ObjectiveTo describe the treatment and outcomes of patients who are medically immunosuppressed due to prior organ transplantation or autoimmune disease with clinical T1 renal cell carcinoma (cT1).MethodsAn institutional database of patients treated f
Externí odkaz:
https://doaj.org/article/289fcbfcce6948e39f0a1bfb18ca804f
Autor:
Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 43-46 (2023)
Patients with metastatic renal cell cancer (mRCC) who respond to upfront immune checkpoint inhibitor (ICI) combination therapies may be treated with cytoreductive nephrectomy (CN) to remove radiographically viable primary tumors. Early data for post-
Externí odkaz:
https://doaj.org/article/1e2ed9e25a3348a2bc31c993f9a5fb19
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, Pp 451-463 (2022)
Renal cell carcinoma (RCC) has a natural tendency to invade the venous system with formation of a venous tumor thrombus in the renal vein, which can extend proximally into the inferior vena cava (IVC) and in some cases into the right atrium. The pres
Externí odkaz:
https://doaj.org/article/2e6a46b89e4147c0a1fc6fdb048aa947
Autor:
Moon Hee Lee, Kyung Sung, David Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto, E. Jason Abel
Publikováno v:
Oncogenesis, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract While an important role for the SUMO protease SENP1 is recognized in multiple solid cancers, its role in renal cell carcinoma (RCC) pathogenesis, particularly the most dominant subtype, clear cell RCC (ccRCC), is poorly understood. Here we s
Externí odkaz:
https://doaj.org/article/5ee96a81e3a44b89bac3dc2f5661c0ee
Autor:
Rory M. Bade, Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino, Joshua A. Desotelle, Erika Heninger, Charlotte N. Stahlfeld, Jamie M. Sperger, Anupama Singh, Serena K. Wolfe, David J. Niles, Waddah Arafat, John A. Steinharter, E. Jason Abel, David J. Beebe, Xiao X. Wei, Rana R. McKay, Toni K. Choueri, Joshua M. Lang
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2330-2344 (2021)
Although therapeutic options for patients with advanced renal cell carcinoma (RCC) have increased in the past decade, no biomarkers are yet available for patient stratification or evaluation of therapy resistance. Given the dynamic and heterogeneous
Externí odkaz:
https://doaj.org/article/e1c2e50d818746e18a79e0890de7a105
Publikováno v:
Société Internationale d’Urologie Journal, Vol 2, Iss Suppl. 1, Pp 18-28 (2021)
None.
Externí odkaz:
https://doaj.org/article/f0fb01c304b54939951d370a15eff374
Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Modeling renal cell carcinoma is critical to investigating tumor biology and therapeutic mechanisms. Multiple systems have been developed to represent critical components of the tumor and its surrounding microenvironment. Prominent in vitro models in
Externí odkaz:
https://doaj.org/article/b81e09b9108146c5976db5d9e38aab49
Autor:
Sara L. Best, Yuming Liu, Adib Keikhosravi, Cole R. Drifka, Kaitlin M. Woo, Guneet S. Mehta, Marie Altwegg, Terra N. Thimm, Matthew Houlihan, Jeremy S. Bredfeldt, E. Jason Abel, Wei Huang, Kevin W. Eliceiri
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background The traditional pathologic grading for human renal cell carcinoma (RCC) has low concordance between biopsy and surgical specimen. There is a need to investigate adjunctive pathology technique that does not rely on the nuclear morp
Externí odkaz:
https://doaj.org/article/befb87aa34df4637819d819ced7bec3a
Autor:
José A. Jiménez-Torres, María Virumbrales-Muñoz, Kyung E. Sung, Moon Hee Lee, E. Jason Abel, David J. Beebe
Publikováno v:
EBioMedicine, Vol 42, Iss , Pp 408-419 (2019)
Background: Anti-angiogenic treatment failure is often attributed to drug resistance, unsuccessful drug delivery, and tumor heterogeneity. Recent studies have speculated that anti-angiogenic treatments may fail due to characteristics inherent to tumo
Externí odkaz:
https://doaj.org/article/4b6ff59ed1d04b059557cb8d4b1a6891
Autor:
Jonathan H. Wang, Pablo Sierra, Kyle A. Richards, E. Jason Abel, Glen O. Allen, Tracy M. Downs, David F. Jarrard
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background To assess factors that can predict active surveillance (AS) failure on serial transrectal ultrasound guided biopsies in patients with low-risk prostate cancer. Methods We evaluated the records of 144 consecutive patients enrolled
Externí odkaz:
https://doaj.org/article/85707b218bca44779c2ac3ed99b25dbb